Subject-Based versus Population-Based Care after Radiation Exposure

In a mass casualty radiation event situation, individualized therapy may overwhelm available resources and feasibility issues suggest a need for the development of population-based strategies. To investigate the efficacy of a population-based strategy, Chinese macaques (n = 46) underwent total-body irradiation and received preemptive antibiotics, IV hydration on predetermined postirradiation days and were then compared to macaques (n = 48) that received subject-based care in which blood transfusions, IV hydration, nutritional supplementation and antibiotic supportive measures were provided. Estimated radiation doses for LD30/60, LD50/60 and LD70/60 of animals with subject-based care: 6.83 Gy (6.21, 7.59), 7.44 Gy (6.99, 7.88) and 8.05 Gy (7.46, 8.64), respectively, and for population-based care: 5.61 Gy (5.28, 6.17), 6.62 Gy (6.13, 7.18) and 7.63 Gy (7.21, 8.20), respectively. Analysis of four time periods, 0–9, 10–15, 16–25 and 26–60 days postirradiation, identified significant mortality differences during the period of 10–15 days. A subset analysis of higher radiation doses (6.75–7.20 Gy, n = 32) indicated hydration, nutrition and septic status were not significantly different between treatments. Whole blood transfusion treatment, administered only in subject-supportive care, was associated with significantly higher platelet and absolute neutrophil counts. Median platelet counts greater than 5,670 cells/μl and absolute neutrophil counts greater than 26 cells/μl during this period correlated with survival. We observed that the population-based treatment increased the LD50/60 compared to nontreatment (6.62 Gy vs. 4.92 Gy) and may be further optimized during days 10–15, where strategic blood transfusions or other strategies to achieve increases in neutrophil and platelet counts may further increase survival rates in subjects exposed to high doses of radiation.

[1]  G. Krigsfeld,et al.  Evidence of Disseminated Intravascular Coagulation in a Porcine Model Following Radiation Exposure. , 2014, Life sciences in space research.

[2]  G. Krigsfeld,et al.  Is Disseminated Intravascular Coagulation the Major Cause of Mortality from Radiation at Relatively Low Whole Body Doses? , 2013, Radiation research.

[3]  C. Olsen,et al.  The Gottingen minipig is a model of the hematopoietic acute radiation syndrome: G-colony stimulating factor stimulates hematopoiesis and enhances survival from lethal total-body γ-irradiation. , 2013, International journal of radiation oncology, biology, physics.

[4]  D. Gridley,et al.  Mechanism of hypocoagulability in proton-irradiated ferrets , 2013, International journal of radiation biology.

[5]  A. Farese,et al.  A Nonhuman Primate Model of the Hematopoietic Acute Radiation Syndrome Plus Medical Management , 2012, Health physics.

[6]  Joseph Albanese,et al.  Literature Review and Global Consensus on Management of Acute Radiation Syndrome Affecting Nonhematopoietic Organ Systems , 2011, Disaster Medicine and Public Health Preparedness.

[7]  Joseph Albanese,et al.  First Global Consensus for Evidence-Based Management of the Hematopoietic Syndrome Resulting From Exposure to Ionizing Radiation , 2011, Disaster Medicine and Public Health Preparedness.

[8]  D. G. Smith,et al.  A simple multiplex polymerase chain reaction to determine ABO blood types of rhesus macaques (Macaca mulatta). , 2011, Tissue antigens.

[9]  K. Sepkowitz,et al.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  James B. Smathers,et al.  Animal Models for Medical Countermeasures to Radiation Exposure , 2010, Radiation research.

[11]  Y. Hamada,et al.  The human‐ABO blood groups of free‐ranging long‐tailed macaques (Macaca fascicularis) and parapatric rhesus macaques (M. mulatta) in Thailand , 2007, Journal of medical primatology.

[12]  A. Farese,et al.  DEFINING THE FULL THERAPEUTIC POTENTIAL OF RECOMBINANT GROWTH FACTORS IN THE POST RADIATION-ACCIDENT ENVIRONMENT: THE EFFECT OF SUPPORTIVE CARE PLUS ADMINISTRATION OF G-CSF , 2005, Health physics.

[13]  James Armitage,et al.  Medical Management of the Acute Radiation Syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group , 2004, Annals of Internal Medicine.

[14]  R. Young,et al.  DOSE RESPONSE RELATIONSHIPS FOR ACUTE IONIZING-RADIATION LETHALITY , 2003, Health physics.

[15]  D. Danilenko,et al.  New strategies for the prevention of radiation injury: possible implications for countering radiation hazards of long-term space travel. , 2002, Journal of radiation research.

[16]  T. Seed,et al.  High-dose antibiotic therapy is superior to a 3-drug combination of prostanoids and lipid A derivative in protecting irradiated canines. , 2002, Journal of radiation research.

[17]  N. Dainiak.  Hematologic consequences of exposure to ionizing radiation. , 2002, Experimental hematology.

[18]  J. T. Horan,et al.  Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. , 2001, Seminars in thrombosis and hemostasis.

[19]  T. MacVittie.  Commentary: Therapy of radiation injury , 1997 .

[20]  C. Baum,et al.  Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor. , 1996, Blood.

[21]  A. Farese,et al.  Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. , 1996, The Journal of clinical investigation.

[22]  D. Lacey,et al.  Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. , 1995, Blood.

[23]  R. Young,et al.  Estimation of median human lethal radiation dose computed from data on occupants of reinforced concrete structures in Nagasaki, Japan. , 1992, Health physics.

[24]  G. Zeman,et al.  The relative biological effectiveness of mixed fission-neutron-gamma radiation on the hematopoietic syndrome in the canine: effect of therapy on survival. , 1991, Radiation research.

[25]  S. J. Baum,et al.  Symptomatology of acute radiation effects in humans after exposure to doses of 0.5-30 Gy. , 1989, Health physics.

[26]  L. Lajtha,et al.  Effect of an Antibiotic Regime on Monkeys Exposed to Total-Body Irradiation , 1964, Nature.

[27]  G. C. Mills,et al.  EFFECTS OF WHOLE-BODY X-IRRADIATION ON ERYTHROCYTE METABOLISM. , 1963, Radiation research.

[28]  E. Cronkite,et al.  The regenerative ability of hemopoietic tissue following lethal x-irradiation in dogs. , 1962, Blood.

[29]  E. Cronkite,et al.  Effectiveness of transfusions of fresh and lyophilized platelets in controlling bleeding due to thrombocytopenia. , 1959, The Journal of clinical investigation.

[30]  W. Jackson.  The effects of low doses of radiation and their relation to permissible dose. , 1959, Radiography.

[31]  Nicholas Dainiak,et al.  The hematologist and radiation casualties. , 2003, Hematology. American Society of Hematology. Education Program.

[32]  T. MacVittie.  Therapy of radiation injury. , 1997, Stem cells.

[33]  V. Klener.  The role of erythropoietin in changes of erythropoiesis after x-irradiation in rats and rabbits. , 1966, Physiologia Bohemoslovaca.

[34]  V. Klener.  Changes in erythropoiesis after whole-body x-irradiation in rats and rabbits. , 1966, Physiologia Bohemoslovaca.

[35]  E. Cronkite,et al.  The hemorrhagic syndrome of acute ionizing radiation illness produced in goats and swine by exposure to the atomic bomb at Bikini, 1946. , 1950, Blood.